Valuation: Remus Pharmaceuticals Limited

Market Cap 10.64B 111M 97.75M 92.61M 83.61M 158M 160M 1.11B 426M 5.44B 417M 408M 17.44B P/E 2025
45.4x
P/E 2026 20x
Enterprise Value 10.36B 108M 95.19M 90.19M 81.42M 153M 155M 1.08B 415M 5.3B 406M 397M 16.99B EV / Sales 2025
2.12x
EV / Sales 2026 0.82x
Free-Float
24.75%
Yield 2025
0.07%
Yield 2026 0.16%
1 day-2.36%
1 week-5.04%
Current month+0.42%
1 month-2.36%
3 months+18.29%
6 months+47.40%
Current year+28.62%
1 week 882
Extreme 882
969.95
1 month 835.1
Extreme 835.1
1,007
Current year 580
Extreme 580
1,007
1 year 580
Extreme 580
1,007
3 years 580
Extreme 580
1,417.38
5 years 213.91
Extreme 213.90625
1,417.38
10 years 213.91
Extreme 213.90625
1,417.38
Manager TitleAgeSince
Chief Executive Officer 39 15/01/2023
Director of Finance/CFO - 08/07/2026
Compliance Officer - 05/01/2023
Director TitleAgeSince
Director/Board Member 39 20/09/2015
Chairman 41 20/09/2015
Director/Board Member 38 20/09/2015
Change 5-day change 1-year change 3-year change Capi.($)
-2.36%-5.04%+22.98%+41.93% 114M
-0.05%+2.15%+54.10%+118.43% 1,056B
-0.10%-0.69%+44.17%+72.30% 645B
+0.20%-0.49%+13.92%+77.93% 465B
-1.70%-1.26%+74.22%+42.58% 368B
-0.06%-3.88%+34.32%+40.74% 335B
-0.79%+2.01%+19.82%+28.48% 275B
-1.19%-1.21%+9.82%+12.15% 255B
-0.06%+4.06%+49.74%+58.68% 229B
-0.75%-0.89%+35.15%+102.46% 188B
Average -0.63%-0.16%+35.82%+59.57% 381.59B
Weighted average by Cap. -0.34%+0.30%+41.11%+73.60%

Financials

2025 2026
Net sales 6.2B 64.7M 56.97M 53.98M 48.73M 91.85M 93.04M 646M 249M 3.17B 243M 238M 10.17B 8.54B 89.03M 78.4M 74.28M 67.06M 126M 128M 889M 342M 4.36B 334M 327M 13.99B
Net income 291M 3.03M 2.67M 2.53M 2.28M 4.3M 4.36M 30.26M 11.65M 149M 11.38M 11.14M 476M 370M 3.86M 3.4M 3.22M 2.91M 5.48M 5.55M 38.51M 14.82M 189M 14.49M 14.17M 606M
Net Debt -42.9M -447K -394K -373K -337K -635K -643K -4.47M -1.72M -21.93M -1.68M -1.64M -70.31M -278M -2.9M -2.56M -2.42M -2.19M -4.12M -4.18M -28.98M -11.15M -142M -10.9M -10.67M -456M
Logo Remus Pharmaceuticals Limited
Remus Pharmaceuticals Limited is an India-based company, which is engaged in marketing and distribution of finished formulations of pharmaceutical drugs. The Company also deals in active pharmaceutical ingredients (APIs). It also provides technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. It offers a range of pharmaceutical formulations and products manufactured on contract manufacturing and on a loan license basis. It deals in drug forms like capsules, cream, eye drops, gel, infusion, inhalation, inhaler, injection, nail lacquer, nasal solution, nasal spray, nebulizer, ointment, ophthalmic, oral gel, oral solution, oral suspension, sachet, suspension and tablet. The Company offers its products in various therapeutic categories, such as oncology, cardiovascular, anti-diabetic, central nervous system (CNS), immunosuppressants, anti-biotic - antibacterial and dermatology.
Employees
69
Date Price Change Volume
30/09/26 ₹903.20 -2.36% 5,400
29/09/26 ₹925.05 +0.60% 4,200
28/09/26 ₹919.50 -2.80% 4,200
25/09/26 ₹946.00 +0.40% 2,700
24/09/26 ₹942.20 -3.59% 4,200
  1. Stock Market
  2. Stocks
  3. REMUS Stock